<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied chromosomes of BM cells from four <z:hpo ids='HP_0001067'>neurofibromatosis</z:hpo> (NF) patients with <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>One patient had a <z:mpath ids='MPATH_458'>normal</z:mpath> diploid karyotype in the <z:hpo ids='HP_0011010'>chronic</z:hpo> phase of juvenile <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JCML</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>When the the <z:hpo ids='HP_0001909'>leukemia</z:hpo> evolved into the accelerated phase, she had cells with 46,XX,-7,+der(7)t(3;7)(q21;p22); the abnormalities resulted in a partial 7p deletion </plain></SENT>
<SENT sid="3" pm="."><plain>In another patient with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JCML</z:e>, BM cells in the accelerated phase had 45,XY,-7 </plain></SENT>
<SENT sid="4" pm="."><plain>The abnormal cells with <z:mp ids='MP_0004026'>monosomy</z:mp> 7 disappeared from the BM after chemotherapy but reappeared later in the course </plain></SENT>
<SENT sid="5" pm="."><plain>Another patient developed <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>) and had cells with 46,XX,-6,+r(6)(p23?q21?); the abnormalities resulted in partial 6p and 6q deletions </plain></SENT>
<SENT sid="6" pm="."><plain>The other patient with ANLL had cells with 45,XX,-7 </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings and review of data on nine other patients suggest that BM cells of NF patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JCML</z:e> in <z:hpo ids='HP_0011010'>chronic</z:hpo> phase have no microscopically detectable chromosome changes and that cells with chromosomal deletion emerge when <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JCML</z:e> evolve into the accelerated or <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast phase</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, deletion of the whole or part of certain chromosomes, such as chromosomes 6, 7, etc., may be an important step towards the evolution of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JCML</z:e> cells or the development of de novo <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> in NF patients </plain></SENT>
</text></document>